SE8403179D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE8403179D0
SE8403179D0 SE8403179A SE8403179A SE8403179D0 SE 8403179 D0 SE8403179 D0 SE 8403179D0 SE 8403179 A SE8403179 A SE 8403179A SE 8403179 A SE8403179 A SE 8403179A SE 8403179 D0 SE8403179 D0 SE 8403179D0
Authority
SE
Sweden
Prior art keywords
sup
sub
carbon atoms
alkyl
hydrogen
Prior art date
Application number
SE8403179A
Other languages
English (en)
Inventor
A E Brendstrom
P L Lindberg
B Wallmark
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20356221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8403179(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8403179A priority Critical patent/SE8403179D0/sv
Publication of SE8403179D0 publication Critical patent/SE8403179D0/sv
Priority to US06/739,425 priority patent/US4636499A/en
Priority to EP85850199A priority patent/EP0171372B1/en
Priority to AT85850199T priority patent/ATE37719T1/de
Priority to DE8585850199T priority patent/DE3565406D1/de
Priority to JP60126398A priority patent/JPH0696581B2/ja
Priority to US06/913,689 priority patent/US4725691A/en
Priority to JP5268822A priority patent/JPH0739412B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
SE8403179A 1984-06-13 1984-06-13 New compounds SE8403179D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8403179A SE8403179D0 (sv) 1984-06-13 1984-06-13 New compounds
US06/739,425 US4636499A (en) 1984-06-13 1985-05-30 Sulphenamides
EP85850199A EP0171372B1 (en) 1984-06-13 1985-06-06 Sulphenamides, processes for their preparation and their use in the manufacture of pharmaceutical preparations
AT85850199T ATE37719T1 (de) 1984-06-13 1985-06-06 Sulphenamide, verfahren zur herstellung von diesen verbindungen und verwendung von obengenannten verbindungen zur herstellung von pharmazeutischen praeparaten.
DE8585850199T DE3565406D1 (en) 1984-06-13 1985-06-06 Sulphenamides, processes for their preparation and their use in the manufacture of pharmaceutical preparations
JP60126398A JPH0696581B2 (ja) 1984-06-13 1985-06-12 新規なスルフエンアミド
US06/913,689 US4725691A (en) 1984-06-13 1986-09-30 2-[8-quinolinyl]-sulphinyl-1H-benzimidazole
JP5268822A JPH0739412B2 (ja) 1984-06-13 1993-10-27 新規なスルホキシド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8403179A SE8403179D0 (sv) 1984-06-13 1984-06-13 New compounds

Publications (1)

Publication Number Publication Date
SE8403179D0 true SE8403179D0 (sv) 1984-06-13

Family

ID=20356221

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403179A SE8403179D0 (sv) 1984-06-13 1984-06-13 New compounds

Country Status (6)

Country Link
US (2) US4636499A (sv)
EP (1) EP0171372B1 (sv)
JP (2) JPH0696581B2 (sv)
AT (1) ATE37719T1 (sv)
DE (1) DE3565406D1 (sv)
SE (1) SE8403179D0 (sv)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8505492D0 (en) * 1985-03-04 1985-04-03 Roussel Lab Ltd Chemical compounds
CA1276017C (en) * 1986-02-13 1990-11-06 Takeda Chemical Industries, Ltd. Sulfenamide derivatives and their production
EP0239129B1 (en) * 1986-03-28 1991-09-25 Otsuka Pharmaceutical Co., Ltd. Hydroquinoline compounds, compositions containing same and processes for preparing same
AU604771B2 (en) * 1986-09-27 1991-01-03 Fisons Plc Pyridinylphenylthio and pyridinylphenylsulphinyl benzimidazone derivatives
WO1989010927A1 (en) * 1988-05-12 1989-11-16 Eisai Co., Ltd. Pyridinium salt and pharmacological composition containing the same
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US20020177608A1 (en) * 2001-04-09 2002-11-28 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
JP2005532356A (ja) * 2002-06-10 2005-10-27 テバ ファーマシューティカル インダストリーズ リミティド 塩酸フェキソフェナジンの多型体ｘｖｉ
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
JP2006188432A (ja) * 2003-02-25 2006-07-20 Zeria Pharmaceut Co Ltd 四環系スルフェンアミド化合物
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
MXPA06012281A (es) * 2004-04-26 2007-07-18 Teva Pharma Formas cristalinas de clorhidrato de fexofenadina y procesos para su preparacion.
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1685106A2 (en) * 2004-09-28 2006-08-02 Teva Pharmaceutical Industries, Inc. Fexofendadine crystal form and processes for its preparation thereof
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
GB2459393B (en) 2006-10-05 2010-09-08 Santarus Inc Novel capsule formulation for the proton pump inhibitor omeprazole
EP2065379A4 (en) * 2006-10-13 2011-01-19 Eisai R&D Man Co Ltd BENZIMIDAZOLE HAVING INHIBITORY ACTIVITY OF GASTRIC ACID SECRETION
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
US8247440B2 (en) 2008-02-20 2012-08-21 Curators Of The University Of Missouri Composition comprising omeprazole, lansoprazole and at least one buffering agent
ES2660876T3 (es) 2012-11-26 2018-03-26 Emcure Pharmaceuticals Limited Derivados de piridona como inhibidores de la secreción de ácido y proceso para la preparación de los mismos
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation

Also Published As

Publication number Publication date
ATE37719T1 (de) 1988-10-15
JPH0696581B2 (ja) 1994-11-30
JPH06316573A (ja) 1994-11-15
JPS617281A (ja) 1986-01-13
EP0171372B1 (en) 1988-10-05
DE3565406D1 (en) 1988-11-10
US4636499A (en) 1987-01-13
US4725691A (en) 1988-02-16
JPH0739412B2 (ja) 1995-05-01
EP0171372A1 (en) 1986-02-12

Similar Documents

Publication Publication Date Title
SE8403179D0 (sv) New compounds
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
NO152130C (no) Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser
ES534723A0 (es) Un procedimiento para la preparacion de dihidropiridinas
SE7709865L (sv) Nya fenyletylaminer och forfarande for framstellning derav
ATE67193T1 (de) 6-phenyl-pyridazin-verbindungen.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES484553A1 (es) Un metodo para preparar 4-fenil-1,3-benzodiazepinas
DE3070847D1 (en) Benzazepine derivatives, process and intermediates for their preparation, their use and pharmaceutical compositions containing them
ES2058275T3 (es) Derivados biciclicos de sulfonamida y su preparacion, su uso y formulaciones que los contienen.
ATE22065T1 (de) Alkan- und alkenderivate und ihre herstellung und verwendung.
IT1193608B (it) Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체
NO165593C (no) Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater.
ES8801202A1 (es) Un procedimiento para preparar derivados de alcanoles aroma-ticos heteropoliciclicos
GB2133012B (en) Quinazolines process for their preparation and pharmaceutical compositions containing them
SE7713779L (sv) Nya fenylderivat
FR2379505A1 (fr) Nouveaux produits doues notamment de proprietes therapeutiques, leurs procedes de preparation, et medicaments a base de ces produits
JPS5711970A (en) Quinazolinone compound and its preparation
Morton Jr et al. Inter-oxa-13, 14-dihydro-PGD 1 compounds
Peterson et al. 12, 13 (E)-Didehydro-13, 14-dihydro-PGD 2 compounds
ES477280A1 (es) Procedimiento para la obtencion de un diastereomero especi- fico de eritro-2-(2-aralquilamino-1-hidroxietil)-1,4-benzo- dioxanos.
GB1457256A (en) 1-phenoxy-2-formyloxy-3-2-cyanochromonyloxy-propanes
JPS5251382A (en) Preparation of novel morpholine derivatives and acid addiio salts ther eof
JPS5251345A (en) Peparation of novel cyclopentanone derivatives